Cercar
01/06/2024
Meteorin-like plasma levels as a novel biomarker for heart failure
Feijoo-Bandin, S, Anido-Varela, L, Tarazón, E, Solé-González, E, Martínez-Sellés, M, Guerra-Ramos, JM, Carrasquer, A, Aragón-Herrera, A, Morán-Fernández, L, Moraña-Fernández, S, González-Maestro, A, García-Vega, D, Portolés, M, Roselló-Lleti, E, Lago, F, González-Juanatey, JR. Meteorin-like plasma levels as a novel biomarker for heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2024
Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacement
Nuche, J, Ternacle, J, Avvedimento, M, Cheema, AN, Veiga-Fernández, G, Muñoz-García, AJ, Vilalta, V, Regueiro, A, Asmarats, L, del Trigo, M, Serra, V, Bonnet, G, Jonveaux, M, Esposito, G, Rezaei, E, de la Torre-Hernández, JM, Fernández-Nofrerías, E, Vidal, P, Gutiérrez-Alonso, L, Oteo, JF, Belahnech, Y, Mohammadi, S, Philippon, F, Modine, T, Mesnier, J, Rodés-Cabau, J. Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacement. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(5)DOI:10.1016/j.rec.2023.11.003. PMID:38000627. IF:4.900(Q1/2D).
01/04/2024
Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis
González-Urbistondo, F, Almenar-Bonet, L, Gómez-Bueno, M, Crespo-Leiro, M, González-Vílchez, F, García-Cosío, MD, López-Granados, A, Mirabet, S, Martínez-Sellés, M, Sobrino, JM, Díez-López, C, Farrero, M, Díaz-Molina, B, Rábago, G, de la Fuente-Galán, L, Garrido-Bravo, I, Blasco-Peiró, MT, García-Quintana, A, de Prada, JAV. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(4)DOI:10.1016/j.rec.2023.10.006. PMID:37984703. IF:4.900(Q1/2D).
01/04/2024
Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation
Witberg, G, Levi, A, Talmor-Barkan, Y, Barbanti, M, Valvo, R, Costa, G, Frittitta, V, de Backer, O, Willemen, Y, van den Dorpel, M, Mon, M, Sugiura, A, Sudo, M, Masiero, G, Pancaldi, E, Arzamendi, D, Santos-Martinez, S, Baz, JA, Steblovnik, K, Mauri, V, Adam, M, Wienemann, H, Zahler, D, Hein, M, Ruile, P, Aodha, BN, Grasso, C, Branca, L, Estévez-Loureiro, R, Amat-Santos, IJ, Mylotte, D, Bunc, M, Tarantini, G, Nombela-Franco, L, Sondergaard, L, Van Mieghem, NM, Finkelstein, A, Kornowski, R. Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation. EuroIntervention. 2024; 20(8)DOI:10.4244/EIJ-D-23-00948. PMID:38629416. IF:9.500(Q1/1D).
03/03/2024
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials
García-Moll, X, Croci, F, Solé, A, Hartgers-Gubbels, ES, Calleja-Hernández, MA. A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials. Expert Review Of Cardiovascular Therapy. 2024; 22(1-3)DOI:10.1080/14779072.2024.2324027. PMID:38416135. IF:(Q/D).
16/02/2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
Carrick, RT, De Marco, C, Gasperetti, A, Bosman, LP, Gourraud, JB, Trancuccio, A, Mazzanti, A, Murray, B, Pendleton, C, Tichnell, C, Tandri, H, Zeppenfeld, K, Wilde, AAM, Davies, B, Seifer, C, Roberts, JD, Healey, JS, MacIntyre, C, Alqarawi, W, Tadros, R, Cutler, MJ, Targetti, M, Calò, L, Vitali, F, Bertini, M, Compagnucci, P, Casella, M, Dello Russo, A, Cappelletto, C, De Luca, A, Stolfo, D, Duru, F, Jensen, HK, Svensson, A, Dahlberg, P, Hasselberg, NE, Di Marco, A, Jordà, P, Arbelo, E, Weidmann, ZM, Borowiec, K, Delinière, A, Biernacka, EK, van Tintelen, JP, Platonov, PG, Olivotto, I, Saguner, AM, Haugaa, KH, Cox, M, Tondo, C, Merlo, M, Krahn, AD, te Riele, ASJM, Wu, KC, Calkins, H, James, CA, Cadrin-Tourigny, J. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe. EUROPEAN HEART JOURNAL. 2024; 45(7)DOI:10.1093/eurheartj/ehad799. PMID:38195003. IF:35.600(Q1/1D).